Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Abbvie Inc. (ABBV) AI Forecast

Our AI detected a significant signal for Abbvie Inc.. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$ABBV Bullish Signal Full forecast available
Sign Up Free

Abbvie Inc. (ABBV) Stock Forecast 2025

Abbvie Inc. (ABBV) AI Stock Price Forecast & Investment Analysis

Abbvie Inc. Stock Price Chart and Technical Analysis

Loading chart...

Abbvie Inc. (ABBV) - Comprehensive Stock Analysis & Investment Research

Deep dive into Abbvie Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on June 6, 2026, 12:21 a.m. (UTC)

Abbvie Inc. Investment Summary

When evaluating whether Abbvie Inc. (ABBV) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Abbvie Inc. (ABBV) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $402 billion, the company is classified as a mega-cap stock, typically characterized by high stability and strong institutional backing.

Financial Performance Analysis

Our comprehensive financial analysis covers Abbvie Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Abbvie Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Abbvie Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Abbvie Inc.

Sign Up Free
Corporate Identity

Abbvie Inc. (Stock Symbol: ABBV) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Abbvie Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Abbvie Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Abbvie Inc....

Unlock Full Company Profile

Get complete details about Abbvie Inc.

Sign Up Free
Revenue & Growth Analysis

Abbvie Inc. generates annual revenues of $63 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Abbvie Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Abbvie Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Abbvie Inc....

Unlock Financial Analysis

Get complete financial metrics for Abbvie Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Abbvie Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Abbvie Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a mega-cap market leader, the company commands significant market influence, enjoying substantial competitive moats including brand recognition, scale economies, and extensive distribution networks. Mega-cap status typically brings advantages in capital access, talent acquisition, and partnership opportunities, while also attracting the highest levels of institutional investor and analyst coverage.

Industry Competitive Landscape

Abbvie Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $20 billion annually . This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Margin & Pricing Power Analysis

The company maintains a 73.4% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of 30.2% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.

Asset Utilization Efficiency

Asset turnover ratio of 0.46x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 0.80 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Abbvie Inc. (ABBV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Abbvie Inc. stock analysis.

Deep dive into Abbvie Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Abbvie Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Abbvie Inc.: With a P/E ratio of 110.62, the market highly values future growth prospects.

P/E Ratio 110.62x
Market Cap $402.12B
Dividend Yield 2.94%
EPS $2.40
Revenue/Share $35.49
FCF/Share $11.29
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Abbvie Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Abbvie Inc.: An ROE of -58.2% indicates room for improvement in shareholder value creation.

ROE -58.2%
ROA 2.8%
ROIC 5.5%
Gross Margin 73.4%
Operating Margin 30.2%
Net Margin 22.4%
EBT Margin 28.6%
Tax Rate 21.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Abbvie Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Abbvie Inc.: A current ratio of 0.80 suggests potential liquidity concerns.

Current Ratio 0.80x
Quick Ratio 0.68x
D/E Ratio -14.45x
Financial Leverage -20.50x
Interest Coverage 5.6x
Working Capital -$8.57B
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Abbvie Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Abbvie Inc.: Free cash flow of $19980M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $4.75B
Free Cash Flow $19.98B
Capital Spending $15.23B
FCF/Sales 31.8%
CapEx/Sales 24.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Abbvie Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Abbvie Inc.: An asset turnover of 0.46x suggests room for improvement in asset utilization.

Asset Turnover 0.46x
Receivables Turnover 5.0x
Inventory Turnover 0.9x
Fixed Assets Turnover 11.1x
Days Sales Outstanding 73 days
Days Inventory 400 days
Payables Period 2673 days
Cash Conversion Cycle -2201 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Abbvie Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Abbvie Inc.: With annual revenue of $62819M, Abbvie Inc. operates at significant scale.

Income Statement
Total Revenue $62.82B
Operating Income $5.22B
Net Income $3.87B
R&D Expense $2.54B
SG&A Expense $4.95B
Cost of Goods Sold $4.61B
Balance Sheet Highlights (% Of Assets)
Total Current Assets 33529%
Cash & Short-term Investments 9391%
Total Liabilities 96157%
Short-term Debt 8326%
Accounts Receivable 12479%
Inventory 5049%
Dividend & Shareholder Information
Dividends Per Share $6.68
Payout Ratio 4.4%
Shares Outstanding 1770M
Growth Metrics (YoY)
Net Income Growth 22.4%
EPS Growth 1.1%

Latest Abbvie Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Abbvie Inc. (ABBV) stock price and investment outlook.

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Abbvie Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Abbvie Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $80M x 0.9x
Abbvie Inc. ABBV ██% $402.12B 110.6x x
Abcellera Biologics Inc. ABCL ██% $1.71B x 1.8x
Abeona Therapeutics Inc. ABEO ██% $310M 4.7x 2.1x
Abbott Laboratories ABT ██% $158.63B 25.3x 3.1x
Arbutus Biopharma Corp ABUS ██% $837M 5.2x 3.2x
Abvc Biopharma, Inc. ABVC ██% $34M x 3.2x
Abivax S.A. ABVX ██% $7.97B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.69B 9.8x 3.0x
Adicet Bio, Inc. ACET ██% $68M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $609M x 4.2x
Acrivon Therapeutics, Inc. ACRV ██% $55M x 0.6x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $7M x 1.0x
Adagene Inc. ADAG ██% $219M x 5.8x
Adc Therapeutics Sa ADCT ██% $131M x x
Adial Pharmaceuticals, Inc. ADIL ██% $5M x 1.3x
Aditxt, Inc. ADTX ██% $50K x x
Addex Therapeutics Ltd. ADXN ██% $7M x x
Aeon Biopharma, Inc. AEON ██% $18M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.68B x 1.5x
Akebia Therapeutics, Inc. AKBA ██% $251M x 9.2x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $17M x 1.2x
Aldeyra Therapeutics, Inc. ALDX ██% $98M x 2.3x
Alkermes Plc. ALKS ██% $7.12B 46.7x 4.1x
Allarity Therapeutics, Inc. ALLR ██% $25M x 3.7x
Alumis Inc. ALMS ██% $2.38B x 4.2x
Alnylam Pharmaceuticals, Inc. ALNY ██% $40.12B 127.9x 50.8x
Altimmune, Inc. ALT ██% $527M x 1.9x
Alx Oncology Holdings Inc ALXO ██% $207M x 1.4x
Alzamend Neuro, Inc. ALZN ██% $4M x 1.9x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.48B x 5.4x
Amphastar Pharmaceuticals, Inc. AMPH ██% $881M 11.1x 1.1x
Amarin Corp Plc\Uk AMRN ██% $292M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.35B 35.6x x
Anaptysbio, Inc ANAB ██% $1.46B x 114.7x
Anebulo Pharmaceuticals, Inc. ANEB ██% $16M x 2.1x
Ani Pharmaceuticals Inc ANIP ██% $1.70B 18.4x 3.0x
Anixa Biosciences Inc ANIX ██% $83M x 5.5x
Annexon, Inc. ANNX ██% $806M x 3.9x
Alto Neuroscience, Inc. ANRO ██% $640M x 2.6x
An2 Therapeutics, Inc. ANTX ██% $137M x 1.7x
Annovis Bio, Inc. ANVS ██% $80M x 25.7x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $9M x 0.2x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $19M x 0.2x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $488M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $207M x 1.1x
Ardelyx, Inc. ARDX ██% $1.37B x 9.2x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.65B x 14.0x
Artelo Biosciences, Inc. ARTL ██% $5M x 0.7x
Arvinas, Inc. ARVN ██% $479M x 1.2x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $10.27B x 16.7x
Aspire Biopharma Holdings, Inc. ASBP ██% $7M x 1.8x
Assembly Biosciences, Inc. ASMB ██% $454M x 2.3x
Ascendis Pharma A/S ASND ██% $13.04B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.45B x 9.1x
Alterity Therapeutics Ltd ATHE ██% $71M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $34M x 14.7x
Atossa Therapeutics, Inc. ATOS ██% $38M x 1.3x
Avenue Therapeutics, Inc. ATXI ██% $1M x 0.9x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.07B 7.0x 3.7x
Arrivent Biopharma, Inc. AVBP ██% $1.38B x 4.2x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $340M x 1.5x
Avalo Therapeutics, Inc. AVTX ██% $689M x 10.1x
Axim Biotechnologies, Inc. AXIM ██% $1M x x
Axsome Therapeutics, Inc. AXSM ██% $11.95B x 218.8x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $3M x 0.3x
Bridgebio Pharma, Inc. BBIO ██% $13.23B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $625M x 1.7x
Bicara Therapeutics Inc. BCAX ██% $1.31B x 2.6x
Briacell Therapeutics Corp. BCTX ██% $27M x 0.9x
Bicycle Therapeutics Plc BCYC ██% $293M x 0.5x
Bioadaptives, Inc. BDPT ██% $80K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $12M x 2.6x
Biofrontera Inc. BFRI ██% $11M x 1.8x
Bio Green Med Solution, Inc. BGMS ██% $8M x 1.2x
Bausch Health Companies Inc. BHC ██% $2.01B x x
Bioharvest Sciences Inc. BHST ██% $72M x 2.8x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $697M x 1.8x
Bio Essence Corp BIOE ██% $12M 9.0x x
Biovie Inc. BIVI ██% $12M x 0.8x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $15M x x
Belite Bio, Inc BLTE ██% $5.64B x 7.3x
Biomea Fusion, Inc. BMEA ██% $92M x 4.9x
Biomarin Pharmaceutical Inc BMRN ██% $10.97B 40.8x 1.8x
Bristol Myers Squibb Co BMY ██% $116.72B 16.0x 5.8x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $362M x 2.0x
Boundless Bio, Inc. BOLD ██% $32M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $9M x 0.4x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $27M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $34M x x
Beyondspring Inc. BYSI ██% $70M x x
Calcimedica, Inc. CALC ██% $17M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.2x
Capricor Therapeutics, Inc. CAPR ██% $1.54B x 5.5x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $346M x 1.0x
Gyre Therapeutics, Inc. CBIO ██% $496M x 4.9x
Cdt Equity Inc. CDT ██% $4M x 0.8x
Cingulate Inc. CING ██% $61M x 3.2x
Cell Source, Inc. CLCS ██% $54M x x
Clene Inc. CLNN ██% $64M x x
Cellectar Biosciences, Inc. CLRB ██% $22M x 6.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $625M x 4.2x
Chemomab Therapeutics Ltd. CMMB ██% $13M x 1.0x
Clearmind Medicine Inc. CMND ██% $4M x x
Compass Pathways Plc CMPS ██% $1.63B x 5.0x
Cnbx Pharmaceuticals Inc. CNBX ██% $110K x x
Cns Pharmaceuticals, Inc. CNSP ██% $7M x 103.4x
Centessa Pharmaceuticals Plc CNTA ██% $6.15B x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $136M x 3.2x
Canton Strategic Holdings, Inc. CNTN ██% $171M x 0.4x
Context Therapeutics Inc. CNTX ██% $161M x 3.1x
Cocrystal Pharma, Inc. COCP ██% $14M x 3.5x
Cogent Biosciences, Inc. COGT ██% $5.60B x 9.2x
Collegium Pharmaceutical, Inc COLL ██% $1.06B 14.1x 3.4x
Corcept Therapeutics Inc CORT ██% $7.82B 165.2x 12.3x
Coya Therapeutics, Inc. COYA ██% $114M x 2.3x
China Pharma Holdings, Inc. CPHI ██% $29M x 0.8x
Cumberland Pharmaceuticals Inc CPIX ██% $88M x 4.0x
Cannapharmarx, Inc. CPMD ██% $2M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.82B 17.3x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $142M x 1.1x
Cormedix Inc. CRMD ██% $664M 3.7x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.51B x 2.7x
Cervomed Inc. CRVO ██% $29M x 2.7x
Corvus Pharmaceuticals, Inc. CRVS ██% $986M x 4.1x
Cytomx Therapeutics, Inc. CTMX ██% $663M x 2.1x
Contineum Therapeutics, Inc. CTNM ██% $461M x 1.8x
Citius Oncology, Inc. CTOR ██% $74M x 2.1x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 5.8x
Citius Pharmaceuticals, Inc. CTXR ██% $15M x 0.3x
Cue Biopharma, Inc. CUE ██% $118M x 5.5x
Curanex Pharmaceuticals Inc CURX ██% $9M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $13M x 7.4x
Cv Sciences, Inc. CVSI ██% $6M x 3.8x
Cyclerion Therapeutics, Inc. CYCN ██% $13M x 1.9x
Cytodyn Inc. CYDY ██% $400M x x
Cypherpunk Technologies Inc. CYPH ██% $104M x 1.2x
Cryoport, Inc. CYRX ██% $811M 10.2x 1.6x
Cytokinetics Inc CYTK ██% $9.81B x x
Dare Bioscience, Inc. DARE ██% $32M x 43.2x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $4M x 0.9x
Journey Medical Corp DERM ██% $170M x 5.5x
Diamedica Therapeutics Inc. DMAC ██% $315M x 6.7x
Damora Therapeutics, Inc. DMRA ██% $1.37B x 2.7x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.59B x 3.8x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $731M x x
Design Therapeutics, Inc. DSGN ██% $672M x 3.1x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $50M x 0.6x
Dyne Therapeutics, Inc. DYN ██% $3.04B x 3.5x
Emergent Biosolutions Inc. EBS ██% $437M x 0.8x
Edesa Biotech, Inc. EDSA ██% $63M x 6.2x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 0.6x
Elanco Animal Health Inc ELAN ██% $12.34B x 1.9x
Eledon Pharmaceuticals, Inc. ELDN ██% $261M x 5.8x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $430M 15.7x 5.4x
Elicio Therapeutics, Inc. ELTX ██% $246M x x
Enliven Therapeutics, Inc. ELVN ██% $2.16B x 4.8x
Emmaus Life Sciences, Inc. EMMA ██% $710K x x
Enlivex Ltd. ENLV ██% $191M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $341M x 2.9x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $7M x 1.4x
Evolus, Inc. EOLS ██% $435M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $421M x 5.1x
Equillium, Inc. EQ ██% $184M x 3.1x
Erasca, Inc. ERAS ██% $3.81B x 9.7x
Ernexa Therapeutics Inc. ERNA ██% $10M x 1.4x
Esperion Therapeutics, Inc. ESPR ██% $787M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $791M x 25.8x
Earth Science Tech, Inc. ETST ██% $52M 12.9x 9.2x
Evofem Biosciences, Inc. EVFM ██% $1M x x
Evommune, Inc. EVMN ██% $745M x 2.5x
Edgewise Therapeutics, Inc. EWTX ██% $4.00B x 8.1x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $89M 0.7x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $6M x 2.1x
Forte Biosciences, Inc. FBRX ██% $342M x 8.1x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $215M x x
Filana Therapeutics, Inc. FLNA ██% $68M x 1.0x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $224M x 0.7x
Galectin Therapeutics Inc GALT ██% $150M x x
Gain Therapeutics, Inc. GANX ██% $72M x 5.1x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $140K x x
Cytomed Therapeutics Ltd GDTC ██% $13M x x
Geron Corp GERN ██% $757M x 3.3x
Gh Research Plc GHRS ██% $1.44B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $5M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $347M x 65.9x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $135M x 5.9x
Genprex, Inc. GNPX ██% $8M x 0.5x
Gossamer Bio, Inc. GOSS ██% $41M x x
Geovax Labs, Inc. GOVX ██% $9M x 18.9x
Structure Therapeutics Inc. GPCR ██% $2.78B x 1.9x
Grace Therapeutics, Inc. GRCE ██% $38M x 0.6x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $20M 0.1x 27.9x
Gsk Plc GSK ██% $102.81B x x
Gt Biopharma, Inc. GTBP ██% $16M x 2.1x
Gyre Therapeutics, Inc. GYRE ██% $552M x 5.5x
Hutchmed (China) Ltd HCM ██% $1.94B 2.1x 1.6x
Hcw Biologics Inc. HCWB ██% $12M x 2.1x
Cybin Inc. HELP ██% $215M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 0.9x
Vyome Holdings, Inc HIND ██% $15M x 2.2x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Rocket One Inc. HOTH ██% $42M x 10.2x
Werewolf Therapeutics, Inc. HOWL ██% $21M x 1.7x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.86B 12.8x 2.0x
Heron Therapeutics, Inc. /De/ HRTX ██% $85M x 9.3x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $135M x 5.8x
Mindwalk Holdings Corp. HYFT ██% $79M x x
Hyperion Defi, Inc. HYPD ██% $45M x 0.8x
Ibio, Inc. IBIO ██% $91M x 1.2x
Impact Biomedical Inc. IBO ██% $58M x 5.1x
Ideaya Biosciences, Inc. IDYA ██% $2.50B x 2.7x
Inflarx N.V. IFRX ██% $270M x x
Igc Pharma, Inc. IGC ██% $30M x 4.8x
Immutep Ltd IMMP ██% $56M x x
Immix Biopharma, Inc. IMMX ██% $601M x 7.1x
Immunome Inc. IMNM ██% $2.24B x 3.8x
Imunon, Inc. IMNN ██% $8M x 2.5x
Immuron Ltd IMRN ██% $11M x x
Immuneering Corp IMRX ██% $294M x 1.4x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $193M x 1.3x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $250M x 200.6x
Indivior Pharmaceuticals, Inc. INDV ██% $4.39B 17.4x x
Inmed Pharmaceuticals Inc. INM ██% $5M x 0.8x
Inovio Pharmaceuticals, Inc. INO ██% $94M x 15.5x
Insmed Inc INSM ██% $22.49B x 31.9x
Inhibitor Therapeutics, Inc. INTI ██% $14M x x
Innoviva, Inc. INVA ██% $1.67B 3.3x 1.2x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $140K x 0.2x
Ionis Pharmaceuticals Inc IONS ██% $12.33B x 25.1x
Opus Genetics, Inc. IRD ██% $342M x x
Disc Medicine, Inc. IRON ██% $2.56B x 3.7x
Ironwood Pharmaceuticals Inc IRWD ██% $533M 5.2x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $844M x x
Incannex Healthcare Inc. IXHL ██% $37M x 0.5x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $827M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.29B 484.7x 3.2x
Jade Biosciences, Inc. JBIO ██% $868M x 2.9x
Johnson & Johnson JNJ ██% $537.72B 25.6x 6.6x
Jupiter Neurosciences, Inc. JUNS ██% $11M x x
Kala Bio, Inc. KALA ██% $42M x 3.9x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.38B x x
Kairos Pharma, Ltd. KAPA ██% $10M x 1.9x
Kaya Holdings, Inc. KAYS ██% $10M x x
Kamada Ltd KMDA ██% $426M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.66B 50.1x 6.0x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $203M x x
Keros Therapeutics, Inc. KROS ██% $207M x 0.7x
Korro Bio, Inc. KRRO ██% $160M x 1.3x
Pasithea Therapeutics Corp. KTTA ██% $20M x 0.4x
Kura Oncology, Inc. KURA ██% $768M x 7.1x
Kyntra Bio, Inc. KYNB ██% $28M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $801M x 2.1x
Legend Biotech Corp LEGN ██% $6.68B x x
Lexaria Bioscience Corp. LEXX ██% $16M x 2.5x
Lifecore Biomedical, Inc. \De\ LFCR ██% $212M x x
Lifevantage Corp LFVN ██% $105M 13.3x 3.2x
Ligand Pharmaceuticals Inc LGND ██% $4.69B 30.6x 4.7x
Longeveron Inc. LGVN ██% $24M x 1.5x
Lianbio LIANY ██% $18M x 0.1x
Lftd Partners Inc. LIFD ██% $3M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $370K x 0.3x
Lite Strategy, Inc. LITS ██% $31M x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $86M x 10.9x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.81B x x
Eli Lilly & Co LLY ██% $1.01T 39.8x 32.3x
Lunai Bioworks Inc. LNAI ██% $13M x x
Lipocine Inc. LPCN ██% $18M x 0.8x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $4.95B 222.0x 45.6x
Larimar Therapeutics, Inc. LRMR ██% $332M x 2.1x
Lisata Therapeutics, Inc. LSTA ██% $31M x 2.8x
Lantern Pharma Inc. LTRN ██% $43M x 12.6x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $809M x 4.0x
Lyell Immunopharma, Inc. LYEL ██% $293M x 1.1x
Maia Biotechnology, Inc. MAIA ██% $87M x 3.1x
Mustang Bio, Inc. MBIO ██% $5M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $13M x 0.9x
Mbx Biosciences, Inc. MBX ██% $1.43B x 3.3x
Seres Therapeutics, Inc. MCRB ██% $69M x 2.6x
Medicus Pharma Ltd. MDCX ██% $20M x 15.3x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.30B x 20.8x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $267M x 12.6x
Mira Pharmaceuticals, Inc. MIRA ██% $42M x 4.5x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.60B x 23.1x
Milestone Pharmaceuticals Inc. MIST ██% $151M x 4.2x
Moonlake Immunotherapeutics MLTX ██% $1.30B x 5.1x
Mineralys Therapeutics, Inc. MLYS ██% $2.07B x 3.2x
Mannkind Corp MNKD ██% $1.05B x x
Medicinova Inc MNOV ██% $65M x 1.7x
Monopar Therapeutics MNPR ██% $406M x 3.0x
Maplight Therapeutics, Inc. MPLT ██% $1.28B x 3.2x
Mereo Biopharma Group Plc MREO ██% $53M x 1.6x
Merck & Co., Inc. MRK ██% $297.28B 33.3x 6.5x
Marker Therapeutics, Inc. MRKR ██% $25M x 1.8x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.79B x 8.4x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $14M x 1.5x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.75B x 5.6x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $346M 17.4x 2.1x
Novabridge Biosciences NBP ██% $187M x 0.7x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $17M x 31.4x
Nucana Plc NCNA ██% $8M x x
Minerva Neurosciences, Inc. NERV ██% $205M x x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.9x
Neurogene Inc. NGNE ██% $408M x 1.7x
Nika Pharmaceuticals, Inc NIKA ██% $212M x x
Nektar Therapeutics NKTR ██% $1.92B x 3.3x
Nkarta, Inc. NKTX ██% $186M x 0.7x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $32M x 3.6x
Nurix Therapeutics, Inc. NRIX ██% $1.60B x 3.3x
Neurosense Therapeutics Ltd. NRSN ██% $28M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $170M x x
Neonc Technologies Holdings, Inc. NTHI ██% $108M x x
Nuvation Bio Inc. NUVB ██% $1.64B x 5.1x
Nuvalent, Inc. NUVL ██% $7.09B x 6.0x
Nuvectis Pharma, Inc. NVCT ██% $247M x 17.4x
Novartis Ag NVS ██% $283.17B x x
Northwest Biotherapeutics Inc NWBO ██% $337M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $11M x 0.4x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.83B x 3.1x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $149M x x
Organon & Co. OGN ██% $3.52B 14.3x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $170M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $918M x 1.9x
Omeros Corp OMER ██% $738M 8.6x x
Beone Medicines Ltd. ONC ██% $28.95B 56.4x 6.1x
Onconetix, Inc. ONCO ██% $1M x 0.1x
Oncolytics Biotech Inc ONCY ██% $101M x x
Opko Health, Inc. OPK ██% $1.09B x 0.9x
Organogenesis Holdings Inc. ORGO ██% $300M 110.3x 1.2x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $811M x 2.0x
Oruka Therapeutics, Inc. ORKA ██% $3.76B x 7.7x
Oramed Pharmaceuticals Inc. ORMP ██% $156M 1.4x 0.7x
Os Therapies Inc OSTX ██% $80M x x
Oncotelic Therapeutics, Inc. OTLC ██% $22M x 0.1x
Ovid Therapeutics Inc. OVID ██% $446M x 2.3x
One World Products, Inc. OWPC ██% $630K x x
Phibro Animal Health Corp PAHC ██% $1.29B 13.5x 3.6x
Prestige Consumer Healthcare Inc. PBH ██% $2.20B 11.6x 1.2x
Psyence Biomedical Ltd. PBM ██% $9M x x
Puma Biotechnology, Inc. PBYI ██% $346M 14.2x 2.7x
Pacira Biosciences, Inc. PCRX ██% $891M 173.4x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $8M x 3.0x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $60M x 15.5x
Pepgen Inc. PEPG ██% $98M x 0.7x
Pfizer Inc PFE ██% $146.20B 19.5x 1.6x
Precigen, Inc. PGEN ██% $1.36B x 67.0x
Phathom Pharmaceuticals, Inc. PHAT ██% $802M x x
Phio Pharmaceuticals Corp. PHIO ██% $13M x 0.8x
Pharvaris N.V. PHVS ██% $2.11B x x
Protokinetix, Inc. PKTX ██% $2M x 8.6x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $73M x 0.4x
Polomar Health Services, Inc. PMHS ██% $2M x x
Promis Neurosciences Inc. PMN ██% $87M x 1.4x
Pmv Pharmaceuticals, Inc. PMVP ██% $62M x 0.7x
Purple Biotech Ltd. PPBT ██% $3M x x
Propanc Biopharma, Inc. PPCB ██% $4M x 0.4x
Praxis Precision Medicines, Inc. PRAX ██% $7.77B x 5.5x
Prf Technologies Ltd. PRFX ██% $2M x 0.2x
Perrigo Co Plc PRGO ██% $1.48B x 0.6x
Prelude Therapeutics Inc PRLD ██% $302M x 5.0x
Prophase Labs, Inc. PRPH ██% $620K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $155M x x
Prothena Corp Public Ltd Co PRTA ██% $473M x 1.5x
Ptc Therapeutics, Inc. PTCT ██% $5.69B x x
Protagonist Therapeutics, Inc PTGX ██% $6.27B x 9.6x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $25M x 2.4x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.3x
Provectus Biopharmaceuticals, Inc. PVCT ██% $26M x x
Palvella Therapeutics, Inc. PVLA ██% $1.65B x 7.1x
Pyxis Oncology, Inc. PYXS ██% $107M x 3.4x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $9M x 1.0x
Quantum Biopharma Ltd. QNTM ██% $31M x x
Q32 Bio Inc. QTTB ██% $228M 6.9x 4.9x
Quantum Cyber N.V. QUCY ██% $56M x 12.2x
Uniqure N.V. QURE ██% $1.88B x 12.6x
Radiopharm Theranostics Ltd RADX ██% $35M x x
Rani Therapeutics Holdings, Inc. RANI ██% $113M x 4.0x
Rapport Therapeutics, Inc. RAPP ██% $1.77B x 3.8x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.20B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $319M x 1.3x
Arcus Biosciences, Inc. RCUS ██% $2.99B x 5.7x
Dr Reddys Laboratories Ltd RDY ██% $11.05B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $65.39B 14.8x 2.1x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $69M x 0.9x
Regen Biopharma Inc RGBP ██% $150K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $557M 1.5x 1.4x
Rocket One Inc. RKTO ██% $48M x 11.5x
Relmada Therapeutics, Inc. RLMD ██% $664M x 3.0x
Rallybio Corp RLYB ██% $85M x 1.7x
Retrieve Medical Holdings, Inc. RMHI ██% $24M x x
Rockwell Medical, Inc. RMTI ██% $28M x 0.8x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $179M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 3.8x
Rein Therapeutics, Inc. RNTX ██% $87M x 7.5x
Renovorx, Inc. RNXT ██% $41M x 3.6x
Roivant Sciences Ltd. ROIV ██% $20.67B x 4.6x
Royalty Pharma Plc RPRX ██% $31.65B 38.3x 4.6x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $8M x 0.5x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.80B x 47.2x
Rezolute, Inc. RZLT ██% $441M x 3.8x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $43M x 2.0x
Scienture Holdings, Inc. SCNX ██% $15M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $371M x 9.0x
Stablecoin Development Corp SDEV ██% $32M 0.1x 0.2x
Schrodinger, Inc. SDGR ██% $1.10B x 3.5x
Septerna, Inc. SEPN ██% $1.37B x 3.6x
Serina Therapeutics, Inc. SER ██% $27M x 1.5x
Sagimet Biosciences Inc. SGMT ██% $424M x 4.1x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 0.9x
Siga Technologies Inc SIGA ██% $318M 15.7x 2.1x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.65B x 5.7x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $27M x 3.0x
Sol-Gel Technologies Ltd. SLGL ██% $232M x 10.2x
Silence Therapeutics Plc SLN ██% $303M x 6.1x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.64B x 15.3x
Summit Therapeutics Inc. SMMT ██% $11.69B x 21.4x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.15B x x
Syndax Pharmaceuticals Inc SNDX ██% $1.62B x 39.0x
Soligenix, Inc. SNGX ██% $7M x 2.3x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $21M x x
Sanofi SNY ██% $107.79B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $135M x 3.9x
Scisparc Ltd. SPRC ██% $6M x x
Spero Therapeutics, Inc. SPRO ██% $162M 10.6x 3.1x
Ars Pharmaceuticals, Inc. SPRY ██% $869M x 14.2x
Sarepta Therapeutics, Inc. SRPT ██% $1.76B 27.0x 1.2x
Stoke Therapeutics, Inc. STOK ██% $1.83B x 4.6x
Shattuck Labs, Inc. STTK ██% $359M x 3.8x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.56B x 2.4x
Savara Inc SVRA ██% $1.08B x 6.1x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $8M x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $6.38B x 9.5x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $49.24B x x
Theravance Biopharma, Inc. TBPH ██% $846M 7.4x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $6M x 4.6x
Telomir Pharmaceuticals, Inc. TELO ██% $86M x 17.3x
Tenax Therapeutics, Inc. TENX ██% $297M x 2.6x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $40.09B 25.6x 4.9x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $6.21B 13.4x 10.7x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $40M x 2.2x
Telix Pharmaceuticals Ltd TLX ██% $3.19B x x
Tango Therapeutics, Inc. TNGX ██% $3.15B x 8.0x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $183M x 0.8x
Theriva Biologics, Inc. TOVX ██% $13M x 0.8x
Tempest Therapeutics, Inc. TPST ██% $19M x 22.7x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $269M x 1.0x
Trevi Therapeutics, Inc. TRVI ██% $1.76B x 10.2x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $165M x 27.0x
Tvardi Therapeutics, Inc. TVRD ██% $29M x 2.0x
Travere Therapeutics, Inc. TVTX ██% $4.38B x 44.4x
Therapeuticsmd, Inc. TXMD ██% $23M 129.3x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.61B x 4.2x
Unicycive Therapeutics, Inc. UNCY ██% $181M x 4.8x
Upstream Bio, Inc. UPB ██% $392M x 1.3x
Urogen Pharma Ltd. URGN ██% $1.32B x x
United Therapeutics Corp UTHR ██% $23.09B 17.9x 3.9x
Vaccinex, Inc. VCNX ██% $2M x x
Vera Therapeutics, Inc. VERA ██% $2.32B x 4.6x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $790K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.37B x 6.7x
Vanda Pharmaceuticals Inc. VNDA ██% $369M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $114M x 7.1x
Viridian Therapeutics, Inc.\De VRDN ██% $1.65B x 2.6x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $113.61B 26.2x 5.9x
Verastem, Inc. VSTM ██% $337M x 4.1x
Vistagen Therapeutics, Inc. VTGN ██% $23M x 0.5x
Viatris Inc VTRS ██% $18.68B x 1.3x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $22M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $206M x 1.8x
Wave Life Sciences Ltd. WVE ██% $1.14B x 2.2x
Xenetic Biosciences, Inc. XBIO ██% $8M x 1.1x
Xbiotech Inc. XBIT ██% $72M x 0.5x
Exicure, Inc. XCUR ██% $20M x 9.4x
Xenon Pharmaceuticals Inc. XENE ██% $5.08B x 3.8x
Xeris Biopharma Holdings, Inc. XERS ██% $1.07B 89.0x 82.1x
Xilio Therapeutics, Inc. XLO ██% $51M x 0.7x
Xencor Inc XNCR ██% $880M x 1.7x
Xoma Royalty Corp XOMA ██% $502M 14.8x 5.4x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $5M x x
Zenas Biopharma, Inc. ZBIO ██% $1.15B x 3.4x
Zai Lab Ltd ZLAB ██% $1.90B x 2.9x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $257M x 1.4x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $33.79B 12.8x 10.5x
Zevra Therapeutics, Inc. ZVRA ██% $629M 5.1x 3.1x
Zyversa Therapeutics, Inc. ZVSA ██% $1M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Abbvie Inc. Stock Forecast

How accurate are Abbvie Inc. stock predictions?

Our AI model shows a -15% Spearman correlation coefficient for ABBV predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Abbvie Inc. stock price forecasts?

Our analysis considers Abbvie Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Abbvie Inc. a good investment in 2025?

Based on our AI analysis, Abbvie Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Abbvie Inc. forecasts updated?

Abbvie Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Abbvie Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...